Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pow.Bio has developed an AI-driven continuous fermentation platform that decouples microbial growth from product formation. This approach increases yields and reduces costs compared to traditional batch processes. The company operates as a "fermentation as a service" provider to the synthetic biology and industrial biotech sectors. Its new Alameda facility demonstrates scalable deployment of its technology for rapid prototyping through pilot-scale manufacturing across food ingredients, chemicals, materials, and potentially pharmaceuticals. The company does not have its own clinical pipeline or results but reports significant efficiency gains in client projects—such as up to fivefold increases in yield depending on organism/product type.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pow.Bio.